422

Compound name
Trametinib
Alt Name
Mekinist
GSK1120212
GSK-1120212
Compound Image
Trametinib.png
SMILES
CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5
MW
615.40
Brutto
C26H23FIN5O4
InChI
InChI=1S/C26H23FIN5O4/c1-13-22-21(23(31(3)24(13)35)30-20-10-7-15(28)11-19(20)27)25(36)33(17-8-9-17)26(37)32(22)18-6-4-5-16(12-18)29-14(2)34/h4-7,10-12,17,30H,8-9H2,1-3H3,(H,29,34)
InChI Key
LIRYPHYGHXZJBZ-UHFFFAOYSA-N
Approval Jurisdiction
2013 FDA 2014 EMA
Approved for clinical use
M-Melanoma With BRAFV600E
CAS
871700-17-3
PubChem CID
11707110
Action
MEK
Approved Drug List
1
Commercial Vendor
GlaxoSmithKline